Search for: "Novartis Pharmaceuticals Corp"
Results 341 - 360
of 367
Sort by Relevance
|
Sort by Date
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA … [read post]
17 Jan 2008, 10:00 pm
: (Against Monopoly),Structuring a decentralized world - Institute for Ethics and Emerging Technologies: The necessity of open biotechnology: (Patent Lens),A skeptical look at the Automated Content Access Protocol: (Ars Technica),5 practical things to incorporate in a corporate IP strategy: (IP ThinkTank), Legal models for online content enforcement: (OpenContentLawyer),Germany, Chinese copies and misdirected ‘strategy': (IP… [read post]
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v… [read post]
27 Dec 2007, 7:09 am
Novartis Pharmaceuticals Corp., 2007 WL 1521138 (D.N.J. [read post]
14 Dec 2007, 1:00 am
: (Patent Prospector) PharmaAggregate launches new online presence: (MaRS Blog - Innovation and Commercialization in Canada)Japan Plans Generic Drug Incentives to Cut Down Medical Costs: (MedIndia), Interesting commentary and article on generic/ innovator company patent settlements: (Generic Pharmaceuticals & IP), Global trends in commencement of patent actions by innovators: (Generic Pharmaceuticals & IP), Is… [read post]
8 Dec 2007, 11:00 am
: (IP Think Tank), WIPO - Idris gets paid out to leave early: (IAM), (Patent Prospector), Deutsche Grammophon ditches DRM: (ArsTechnica)PharmaFDA revisits NCE exclusivity for enantiomers: (Arnall Golden & Gregory), Accupril (Quinapril) - Judge finds against Teva and holds Warner-Lambert patent enabled: (IPLaw360), (OrangeBookBlog), Altace / Tritace / Ramace (Ramipril) - King Pharmaceuticals loses CAFC rehearing bid: (IPLaw360), … [read post]
25 Nov 2007, 11:04 am
Novartis Pharmaceuticals Corp., No. 06-6280 (JBS), 2007 WL 1521138 (D.N.J. [read post]
23 Nov 2007, 9:00 am
Astra's Data Exclusivity prevents a European generic launch, until at least 2010.: (Generic Pharmaceuticals & IP), Iressa (gefitinib) - Astrazeneca's Indian patent application rejected: (Generic Pharmaceuticals & IP), Ziagen (Abacavir Hemisulfate Salt) -GSK's application [872/CAL/98; corresponding to Orange Book listed US6294540] opposed by Indian Network for People living with HIV/ AIDS and then withdrawn by GSK: (Generic Pharmaceuticals… [read post]
16 Nov 2007, 4:00 am
: (LawFont),BrazilBrazil pays the price for compulsory licensing: (IAM), (Generic Pharmaceuticals & IP), CanadaThe Chronicle reports that Honourable Mr. [read post]
2 Nov 2007, 11:00 pm
: (PLI), (PatentDocs), (Patent Baristas), (Patently'O), Vonage settles patent dispure with Verizon: (IP Law360), Celgene and Novartis file extended release Ritalin suit: (IP Law360), T-Mobile USA is the latest to settle charges that it infringed technology for computerized sales methods held by patent-holding company Orion IP LLC: (IP Law360),Bayer beats Dr Reddy's on Avelox (moxifloxacin): (OrangeBookBlog), (Generic Pharmaceuticals), Martek obtains permanent injunction… [read post]
26 Oct 2007, 1:00 am
(Korea IP Law Blog), Korean trade mark law governs domain name disputes in Korea (Korea IP Law Blog), SpainLipitor patent upheld in Spain: (IPLaw 360), United Kingdom House of Lords overturns the Court of Appeal in the Yeda Appeal over Erbitux: (IPKat), (Inner Temple), (IP Law360), Novartis AG v IVAX Pharmaceuticals UK Ltd [2007] EWCA Civ 971, Court of Appeal dismisses an appeal against the decision of Mr Justice Pumfrey that Novartis' patent for a… [read post]
18 Oct 2007, 10:33 pm
A long time ago - blogwise, anyway - we put together a post that described and linked to all the FDA's amicus curiae briefs that the Agency had filed in favor of preemption in prescription drug and medical device product liability litigation. [read post]
12 Oct 2007, 7:03 am
Novartis Pharmaceuticals Corp., 2007 WL 2330713, at *4 (S.D. [read post]
2 Oct 2007, 4:08 am
Novartis Pharmaceuticals Corp. , --- F.R.D. ----, 2007 WL 2197800 (S.D.N.Y., July 31, 2007) (NO. 04 CIV 9194 GEL):Certification under Rule 23(b)(2) is appropriate where "(1) the positive weight or value to the plaintiffs of the injunctive or declaratory relief sought is predominant even though compensatory or punitive damages are also claimed, and (2) class treatment would be efficient and manageable, thereby achieving an appreciable measure of judicial economy. [read post]
27 Sep 2007, 11:38 am
Novartis Corp., 378 F. [read post]
16 Aug 2007, 7:20 am
Suzuki Motor Corp., 996 S.W.2d 47, 63 (Mo. 1999) ("most common" waiver of physician-patient privilege "involve[s] plaintiffs who voluntarily place their medical condition in issue by . . . alleging that they suffered physical or mental injuries"); Marsh v. [read post]
7 Aug 2007, 1:20 am
Novartis Pharmaceuticals Corp. [read post]
2 Aug 2007, 12:44 pm
In his order, the judge also granted a request to dismiss claims against Novartis Corp., the pharmaceutical unit's U.S. parent. [read post]
19 Jun 2007, 9:44 am
Also, Qualcomm was a signer, as were WARF, Cornell University, Monsanto, and Novartis. [read post]
7 Jun 2007, 10:52 am
Sandoz Pharmaceuticals Corp., 77 F. [read post]
